HHS awards Hologic $4.1 million to develop Zika blood test

Healthcare IT News: The U.S. Department of Health and Human Services has awarded $4.1 million to Hologic for the development of a blood-screening test to detect Zika in the blood supply.

Under the one-year agreement, Hologic, the Marlborough, Massachusetts-based diagnostics and imaging company, will advance the development of its Procleix Zika Virus Assay, which is designed to detect Zika virus ribonucleic acid – RNA – in donated blood plasma.

Read article